MERCK HEALTHCARE KGAA - DE 

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 5.999.381 564.480 1
2021 0 6.459.797 505.577 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
BAR ILAN UNIVERSITY1
BAYER1
CENTRE DE REGULACIO GENOMICA1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
F HOFFMANNLA ROCHE1
FORSCHUNGSVERBUND BERLIN EV1
FORSCHUNGSZENTRUM JULICH1
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS1
GSAP BIOMED1
HADASSAH MEDICAL ORGANIZATION1
HEPTARES THERAPEUTICS LIMITED1
IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON1
IMMUNYX PHARMA1
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES1
INTERLAB1
JANSSEN PHARMACEUTICA NV1
KAROLINSKA INSTITUTE1
KATHOLIEKE UNIVERSITEIT LEUVEN1
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS1
STICHTING VUMC1
TERMESZETTUDOMANYI KUTATOKOZPONT1
THE HEBREW UNIVERSITY OF JERUSALEM1
UNIVERSITAET GREIFSWALD1
UNIVERSITAT DE BARCELONA1
UNIVERSITAT WIEN1
UNIVERSITATSKLINIKUM ERLANGEN1
UNIVERSITE LOUIS PASTEUR STRASBOURG 11
UNIVERSITEIT ANTWERPEN1
UNIVERSITY OF BIRMINGHAM1

Constancy:

Total number of partners: 29
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 29
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2022-06-01RNA PROCESSING FOR ANTI-CANCER IMMUNOTHERAPY CANCERNAparticipant5.999.38113
2021-09-01Allostery in Drug Discovery ALLODDparticipant3.669.35413
2021-01-01Drug Absorption in Geriatric Patients and Older People: a training network innovating drug development for the advanced age population AGePOPparticipant2.790.4436